about
APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathyWorldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in AfricaPolymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals.Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDS.A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population.Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.Role of exonic variation in chemokine receptor genes on AIDS: CCRL2 F167Y association with pneumocystis pneumonia.Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS.Modulating influence on HIV/AIDS by interacting RANTES gene variantsGenetic influence of CXCR6 chemokine receptor alleles on PCP-mediated AIDS progression among African Americans.Regulatory variation in HIV-1 dependency factor ZNRD1 associates with host resistance to HIV-1 acquisitionGenetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV Type 1 transmission and AIDS disease progression.A common HLA-DPA1 variant is a major determinant of hepatitis B virus clearance in Han Chinese.Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression.Patterns of ethnic diversity among the genes that influence AIDS.Multicohort genomewide association study reveals a new signal of protection against HIV-1 acquisition.Role of APOBEC3F Gene Variation in HIV-1 Disease Progression and Pneumocystis Pneumonia.Screening low-frequency SNPS from genome-wide association study reveals a new risk allele for progression to AIDSMultiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS.APOBEC3B deletion and risk of HIV-1 acquisitionIdentifying Darwinian selection acting on different human APOL1 variants among diverse African populations.Focal segmental glomerulosclerosis is associated with a PDSS2 haplotype and, independently, with a decreased content of coenzyme Q10.Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma.APOBEC3G genetic variants and their influence on the progression to AIDS.Association of Polymorphisms in the Regulatory Region of the Cyclophilin a Gene (PPIA) with Gene Expression and HIV/AIDS Disease Progression.Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection.A tumor necrosis factor-alpha-inducible promoter variant of interferon-gamma accelerates CD4+ T cell depletion in human immunodeficiency virus-1-infected individuals.The effect of RANTES chemokine genetic variants on early HIV-1 plasma RNA among African American injection drug users.Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans.Host and Viral Genetic Variation in HBV-Related Hepatocellular CarcinomaThe Loss-of-Function S267F Variant in HBV Receptor NTCP Reduces Human Risk for HBV Infection and Disease ProgressionIFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral InfectionsImpact of Genetic Variants on HIV-1 Infection and Disease ProgressionValidation of genetic case-control studies in AIDS and application to the CX3CR1 polymorphismDominant effects of CCR2-CCR5 haplotypes in HIV-1 disease progressionThe Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) PathogenesisHost Genetics of Cytomegalovirus Pathogenesis
P50
Q24631837-3BBB1A7D-0714-489F-9487-BEA6B3B7212EQ28750412-7DB82498-633B-40AB-A44E-D7B96346BB90Q33270513-BECB12A9-7219-4B68-8B08-410DB3623605Q33288731-AF455DF7-66C5-4EE0-935B-5596A34DE992Q33313034-2DC3B30D-900F-47D1-98CB-022938C2B9ADQ33773661-EC70DFA2-E31F-4809-94FD-4DD01EBEFD88Q34064248-DFC02AFC-D025-46C1-80CC-7D7BDAA5057BQ34085996-19EB652F-5D5C-4535-B733-1D4AAF987A7CQ34098634-EB52014F-5A9A-4428-B255-4D619824E1FAQ34199154-B6A6B830-CB73-4429-9C82-1BFE8EEB5280Q34430206-C659FB00-6E15-420E-92D1-868A661F4A4EQ34658462-295A4C77-EEBF-46E7-90C8-108E1EC2DA73Q34743365-995F9F38-CDF8-4D7B-91CA-DC057670CE0BQ35600919-9CB0B21A-117B-4BCB-8F72-2263BA8FAB44Q35649567-91B57996-C190-42FC-B25D-2752D5AEF8ADQ35808621-DA4E8062-D486-4A18-BE91-0BD60A98DF97Q35945852-029B47E1-B044-4875-9F4F-7D219D190EE3Q36068205-A8F73219-8C66-4586-9BB8-AE95251421A0Q36696711-6384D9B1-9314-4AB2-AA4D-37D585E3A3D7Q36949248-D3E46319-730E-40B2-BF97-BE85D7B38E70Q37010357-815D2466-25D5-43FF-BFCC-E1376172A8BEQ37234710-A683D82B-BA12-47DE-BD85-359D251AA20CQ37317414-FA0B8B7F-848B-4292-905E-D093CB4EEA57Q37567867-78EB68D7-9DDE-41A7-8D3B-8B86969FB180Q39843465-30E8AA19-E23F-4B94-864C-FCA5EE9F22ADQ40248116-8839A16D-DB9F-435F-81B5-75CD66C330C6Q45722663-6AD3D3B3-8746-4B2E-B8C3-A1654592168BQ46494978-53AB3E83-FA1C-437A-8E13-394CDC863CF3Q46821866-A4D820E0-B3DF-4D2F-A52D-F887317C36A6Q56976434-29030BD6-A252-411A-A67F-08C117018E73Q59358695-C1C76557-E643-47A6-8400-B0750E75D2DAQ61450240-5CAC51B2-A143-4C8D-BC44-5B9F5F34819DQ61810269-7BE5396D-D0BB-42E6-9109-C5564D00A683Q73968273-B6E4B0BB-AC83-4A0D-A748-3BAC86CF62B2Q81152972-3E38AD48-6F76-42CF-8C7B-4ED0C803DA17Q91469110-82DB935F-7423-42F1-9D82-8E91E5552408Q92511518-F1D3E19D-C0A7-480D-8AE1-702CA1B620A0
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ping An
@ast
Ping An
@en
Ping An
@es
Ping An
@nl
Ping An
@sl
type
label
Ping An
@ast
Ping An
@en
Ping An
@es
Ping An
@nl
Ping An
@sl
prefLabel
Ping An
@ast
Ping An
@en
Ping An
@es
Ping An
@nl
Ping An
@sl
P106
P31
P496
0000-0002-5322-3510